Ardelyx | ARDX - Operating Expenses

Stock Price
6.04
Daily Change
0.10 1.68%
Monthly
-2.11%
Yearly
35.73%
Q2 Forecast
5.76

Ardelyx reported $120.12M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Amgen USD 5.9B 773M Dec/2025
Ardelyx USD 120.12M 14.46M Dec/2025
aTyr Pharma USD 85.61M 58.67M Dec/2025
Corcept Therapeutics USD 197.64M 219K Dec/2025
Curis USD 9.02M 23.01M Dec/2025
Sanofi EUR 10.71B 1.32B Dec/2025
TG Therapeutics USD 142.08M 9.74M Dec/2025
United Therapeutics USD 804.8M 5.79B Dec/2025
Xoma USD 22.84M 1.67M Sep/2024